Skip to main content
. 2021 Feb 16;12(2):378–392. doi: 10.1002/jcsm.12680

Figure 6.

Figure 6

Tissue inhibitor of metalloproteinases‐1 (TIMP‐1)/liver cachexia (TLC) score predicts survival of pancreatic cancer (PC) patients. Survival of PC patients separated by plasma levels of TIMP‐1 (A, n = 84, cut‐off: 300 ng/mL TIMP‐1), or serum levels of C‐reactive protein (CRP) (B, n = 66, cut‐off: 0.3 mg/dL CRP), gamma‐glutamyl transferase (GGT) (C, n = 80, cut‐off: 120 U/L GGT), albumin (D, n = 72, cut‐off: 4.0 g/dL albumin), ferritin (E, n = 30, cut‐off: 300 ng/mL ferritin), or total protein (F, n = 62, cut‐off: 6.0 g/dL total protein). Survival of PC patients separated by the TLC score (G, n = 76), the tumour (T) status (H, n = 74), the lymph node (N) status (I, n = 73), the metastasis (M) status (J, n = 70), or the Union for International Cancer Control (UICC) classification (K, n = 76).